Orthopediatrics (KIDS) EBT Margin (2016 - 2026)
Orthopediatrics' (KIDS) quarterly EBT Margin came in at 18.29% in Q1 2026, up 167.0% year-on-year from 6.85% in Q1 2025, and down 15.42% on a QoQ basis from 15.85% in Q4 2025.
Orthopediatrics (KIDS) EBT Margin (2016 - 2026) Analysis & Trends
Orthopediatrics (KIDS) has 11 years of EBT Margin data on file, last reported at 18.29% in Q1 2026.
- On a quarterly basis, EBT Margin rose 167.0% year-over-year to 18.29% in Q1 2026; TTM through Mar 2026 was 16.27%, a 353.0% increase from a year earlier, with the FY2025 full-year figure at 16.58%, up 390.0% from the prior year.
- EBT Margin for Q1 2026 stood at 18.29%, down from 15.85% in the prior quarter.
- Over the last five years, EBT Margin for KIDS reached as high as 41.19% in Q3 2022 and fell as low as 40.21% in Q1 2022.
- Historically, EBT Margin has averaged 14.93% across 5 years, with a median of 18.29% in 2026.
- Across the five-year window, EBT Margin surged 5111 bps in 2022 and slumped 5055 bps in 2023, its largest moves.
- Year by year, EBT Margin stood at 25.48% in 2022, then climbed by 28 bps to 18.35% in 2023, then sank by 70 bps to 31.16% in 2024, then surged by 49 bps to 15.85% in 2025, then slipped by 15 bps to 18.29% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 18.29% in Q1 2026, 15.85% in Q4 2025, and 19.43% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Orthopediatrics | 443.38 Mn | 429.14 Mn | 43.39 Mn | -18.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.29% |
| Dec 31, 2025 | -15.85% |
| Sep 30, 2025 | -19.43% |
| Jun 30, 2025 | -11.56% |
| Mar 31, 2025 | -19.96% |
| Dec 31, 2024 | -31.16% |
| Sep 30, 2024 | -16.74% |
| Jun 30, 2024 | -11.45% |
| Mar 31, 2024 | -23.13% |
| Dec 31, 2023 | -18.35% |
| Sep 30, 2023 | -9.36% |
| Jun 30, 2023 | -8.31% |
| Mar 31, 2023 | -23.36% |
| Dec 31, 2022 | -25.48% |
| Sep 30, 2022 | 41.19% |
| Jun 30, 2022 | -2.34% |
| Mar 31, 2022 | -40.21% |
| Dec 31, 2021 | -0.67% |
| Sep 30, 2021 | -9.92% |
| Jun 30, 2021 | -15.14% |